INTRODUCTION
Hepatitis C virus (HCV) is a positive-strand RNA virus that infects 170 million people worldwide [1] and is the most common reason for liver transplantation in the western world [2] . Current treatments for HCV (interferon or interferon and ribavirin) are not very effective and result in elimination of the virus in only 20-40% of patients [2] . New treatments for HCV are urgently needed.
Translation of the HCV polyprotein initiates at a highly structured internal ribosome entry site (IRES) at the 5Ј end of the genomic RNA. The 3Ј-untranslated region (UTR) of HCV also contains an unusual and highly structured region, termed the 3Ј X region [3, 4] , that may influence translational regulation from the IRES [5] . It has been proposed that the highly conserved 5Ј- [6] and 3Ј-UTRs [3] would be good targets for therapeutic intervention. Extensive effort has been devoted to the development of antisense oligonucleotides and ribozyme inhibitors targeting the conserved HCV IRES sequence [7] . However, testing of these nucleic acid inhibitors in vivo has been hampered by the lack of a convenient small-animal model for HCV IRES function. Recently, a mouse xenotransplantation model was reported that supports HCV viral replication in transplanted human liver cells [8] . While very exciting, this system requires access to fresh human liver tissue. So far, no small-animal model amenable to highthroughput screening of HCV IRES inhibitors has been described.
Cell extract and cell culture translation assays have been invaluable for studies of translational initiation at the HCV IRES. They have been used to map the IRES 5Ј and 3Ј boundaries, to identify essential sequences and secondary structures, and to identify protein-binding sites within the IRES [reviewed in 9, 10] . Specific domains in the IRES contribute to its translational activity both in vitro and in cell culture assays. However, conflicting results from different reports are difficult to reconcile because of differences in the model systems used by the various researchers. There are several reports that cell culture assays have more stringent requirements for efficient translation than cell lysate assays [11, 12] . The type of lysate or cell line used [12] , the concentration of salts in cell lysates [10, 12] , ARTICLE doi:10.1006/mthe.2002.0600, available online at http://www.idealibrary.com on IDEAL and the transcriptional start sequence may also influence translational readout [13] . A recent report that HCV IRES translation varies with cell cycling [14] also raises concern that rapidly dividing cells in tissue culture may not accurately model the translation of viral proteins in the normally quiescent human liver [15, 16] . Differences between in vitro and cell culture assays led Kamoshita et al. to suggest that an in vivo method to measure HCV IRES activity in tissues would be desirable [12] . A comprehensive comparison of IRES function in cell lysates, in cultured cells, and in the liver of a small animal has not been conducted.
These concerns prompted us to develop a mouse model to study translation from the HCV IRES in living mice. To accomplish this, we adapted previously described hydrodynamic transfection methods [17] [18] [19] [20] [21] 
RESULTS

Transfer of Functional RNA to the Livers of Mice
High-pressure injection of naked DNA into the tail vein of rodents leads to efficient transgene expression in the liver [17] [18] [19] [20] . Modest transfection of muscle cells by direct injection of luciferase RNA has also been reported [22] . Chang et al. reported that hydrodynamic transfection of hepatitis delta virus (HDV) DNAs or RNAs into mice led to initiation of a viral replication cycle [21] . This demonstrated that naked RNA injection was a viable method for initiating a viral replication cycle; however, parameters for achieving high-level RNA transfection were not elucidated. One goal of our studies was to establish the important variables required to achieve efficient transfer of RNA to the livers of living mice. We monitored expression of the RNA by whole-body imaging of in vivo luciferase activity, a method that has previously been used to monitor tumor cell proliferation [23] , bacterial infection [24] , in vivo DNA transfer, and gene expression [25] in living mice.
We injected luciferase-encoding RNAs either with no RNase inhibitor or in combination with various amounts of RNase inhibitor or competitor RNA into mice. We used light transmitted through the tissues of treated animals as a measure of luciferase enzyme activity. We mixed 50 mg of 7-methylguanosine-capped and polyadenylated RNA coding for the luciferase gene with the ribonuclease inhibitor, RNasin, as well as an uncapped, nonpolyadenylated competitor RNA (compRNA), and injected the mixture into the tail veins of mice. Figure 1A shows an image of light emitted from a mouse 3 hours after RNA injection; considerable levels of luciferase activity can be observed in a discrete location in the animal. This image consisted of a pseudocolor pattern representing intensity of emitted light (red most and blue least intense), superimposed on a gray-scale reference background image of the animal (for orientation).
To exclude the unlikely possibility that the observed luciferase activity was the result of DNA contamination, we injected two control preparations into mice. The first control contained 2.5 g of linearized template DNA for luciferase RNA transcription (equivalent to the DNA used to generate 50 g of luciferase RNA). Even if the template DNA survived DNase I treatment and purification on a silica membrane (removes DNA), it does not contain a
FIG. 1.
In vivo imaging of luciferase activity. Light emitted as a result of in vivo luciferase activity from expressed protein was used to monitor hydrodynamic luciferase RNA transfection. RNAs were mixed with 400 units of native RNasin (Promega), competitor RNA (to give 80 g total nucleic acid), 2 ml of 25ЊC PBS, and injected under high pressure into the tail veins of mice over 4-5 seconds. After 3 hours, luciferin (the substrate of luciferase) was injected i.p., and living animals were imaged under general anesthesia 10 minutes later using a CCD camera as described [25] . 
Localization of Hydrodynamically Transfected RNAs
The method by which hydrodynamically transfected DNA enters cells remains controversial, although it has been proposed that entry might occur via receptor-mediated endocytosis [26] . If a specific receptor is required for cell entry, it is not clear that transfected RNAs and DNAs would have the same localization. Alternatively, DNA may enter cells by transient disruption of the cell membrane as the result of external pressure [26] . If this is the case, one might expect that hydrodynamically transfected RNAs and DNAs would be localized to the same tissues and subcellular compartments. To clarify this issue, we employed whole-organ imaging as well as in situ hybridization to examine the localization of hydrodynamically transfected RNAs.
To identify the organs targeted by hydrodynamic RNA transfection, we injected 50 g of luciferase RNA. We injected luciferin intraperitoneally (i.p.) 3 hours postinjection; the mouse was killed 10 minutes later and its internal organs imaged. Luciferase activity was detectable in the liver and injection site, but not in any other tissue analyzed (muscle, spleen, kidneys, intestine, lung, heart, and brain) (Fig. 1D ). Because luciferin has been shown to gain access to many tissues when injected i.p. [25] , these results demonstrate that hydrodynamic RNA transfection leads to substantial RNA transfection of primarily the liver.
To determine the subcellular localization of injected RNAs, we conducted in situ hybridization on liver sections at the level of light microscopy (Figs. 2A, 2B, and 2C) and electron microscopy (Figs. 2D and 2E). Specific staining in the cytoplasm with an antisense probe was seen in 33% (± 2.5%) of mouse hepatocytes and nonparenchymal cells (Figs. 2A and 2B), with no staining using a sense RNA probe (Fig. 2C ). Standard transfection methods frequently result in RNA entrapment in endosomal compartments [27] . Using electron microscopy, we observed considerable levels of hybridization (groups of particles bound to multiple digoxigenin molecules within each probe) exclusively within the cytoplasm of transfected cells using an antisense probe (Fig.  2D) . No hybridization occurred with a sense probe used in a control experiment (Fig. 2E) . Collectively, these results show that hydrodynamic RNA transfection can efficiently target considerable amounts of RNA to the cytoplasm of mouse liver cells, with the desired subcellular localization for HCV RNAs. The almost immediate appearance of free RNA in the cytoplasm argues against receptor-mediated endocytosis and for transient membrane disruption.
Amount of Emitted Light Is Dependent on Dose of
Coinjected RNasin, the Presence of Competitor RNA, and the Dose of Luciferase RNA We conducted two experiments to determine further the dependence of luciferase activity on the amount of injected RNasin, competitor RNA, and luciferase RNA. We 3A ; n = 3 per group). In the absence of RNasin, there was no detectable luciferase expression (n = 4), even using a camera that is ~ 100-fold more sensitive than the instrument used to collect the original data. In the absence of competitor RNA, increased amounts of RNasin (between 400 and 1200 units) gave increased luciferase expression. At all doses of RNasin, inclusion of competitor RNA increased luciferase expression. In the presence of competitor RNA, 800 units of RNasin resulted in more intense signals than 400 units, and the signal intensity was comparable to that observed with 1200 units. RNasin and competitor RNA presumably protect luciferase RNA in vivo by competitively binding RNases present in the bloodstream and extracellular space. It is unclear whether RNasin alters intracellular RNA stability, although RNasin added to injected luciferase plasmids did not increase expression from these DNAs (data not shown). Another dose experiment with 5, 20, and 50 g of luciferase RNA ( Fig. 3B ; n = 5, 5, and 6 for groups receiving 5, 20, and 50 g of RNA, respectively) demonstrated a dose-dependent increase in luciferase activity.
Rate of Decay of Luciferase Activity Sets a Limit on Luciferase Half-Life
We monitored changes in luciferase expression every 3 hours after in vivo RNA delivery (n = 5 for 3-hour time point and n = 6 for 6-, 9-, and 12-hour time points). Analyses of light emission in treated mice showed exponential RNA decay in vivo, with an apparent rate constant of 0.3 h -1 (Fig. 4) . Working with these results, we estimated an upper limit for the t 1/2 of luciferase protein in the liver to be ~ 2.3 hours. This is shorter than the t 1/2 estimations of 3 hours obtained in cell culture studies [28] . This may reflect differences in protein stability in the cultured cells used compared with mouse hepatocytes. These results demonstrate that hydrodynamic RNA transfection can be used to estimate protein half-lives in mice.
Transduced HCV Genomic RNAs Do Not Replicate in Mouse Liver
Currently, primates are the only mammals that have been shown to support replication of HCV. Kolykhalov et al. showed that HCV genomic RNAs made in vitro were infectious and caused disease in chimpanzees after direct intrahepatic inoculation [29] . A replication-defective genomic RNA with an in-frame deletion in the NS5B polymerase was used as a negative control. Inoculation of mice with infectious HCV particles does not lead to a viral replication cycle (data not shown). It is unclear whether this result is due to a lack of a receptor for HCV internalization on the surface of mouse hepatocytes, or due to a block in replication that occurs after internalization. (A) Relative light units per minute emitted from animals that were injected with 20 g of luciferase RNA and 400, 800, or 1200 units of RNasin with or without 60 g of competitor RNA. Animals were imaged at 3 hours (n = 3). In the absence of competitor RNA, increasing RNasin doses gave increased luciferase activity. In the presence of competitor RNA, 800 and 1200 units of luciferin gave comparable activity that was greater than with 400 units. (B) Relative light units emitted from mice injected with 5, 20, or 50 g of luciferase RNA and 60 g of competitor RNA. Animals (n = 5, 5, and 6 for groups receiving 5, 20, and 50 g of RNA, respectively) were imaged at 3 hours postinjection. Error bars indicate SEM calculated for each group. Increasing doses of luciferase RNA gave increasing luciferase activity.
A B ARTICLE
We next determined if bypassing the internalization step by transfection of mouse liver with HCV genomic RNA would lead to RNA replication. HCV genomic RNA or RNA containing inactivating substitutions in NS5B (rep -RNA) were injected into mice. Mixtures containing 40 g of genomic (or rep -RNA), 40 g of a capped polyadenylated RNA encoding human factor IX (FIX RNA), 40 g competitor RNA, and 800 units of RNasin were hydrodynamically injected into NOD/LtSz-Prkdcscid mice. We measured serum FIX levels by ELISA 3 hours after injection and used them to correct for RNA transduction efficiency. At various times, animals were killed and RNA was extracted from serum and liver for analysis. We then used quantitative RT-PCR to measure HCV and mouse glyceraldehyde 3-phosphate dehydrogenase (GAPD) levels in these samples (normalized values = (HCV RNA/GAPD)/FIX). Figure 5 shows the decay of HCV genomic RNA and rep -RNA in mouse liver. Both RNAs decay with similar t 1/2 values of ~ 22 hours, suggesting that replication of the genomic RNA does not occur in mouse liver. Serum measurements of genomic RNA and rep -RNA at various times were also similar (data not shown). It is clear from the data in Figures 1 and 2 that hydrodynamically transfected RNA reached the cytoplasm of hepatocytes and was functional. Taken together, our data suggest that there was a post-entry block to HCV replication in mice. We next used hydrodynamic RNA transfection to examine the functionality of the HCV 5Ј-and 3Ј-UTR in mouse liver, and to compare these results with reported data from standard in vitro and culture models.
Translational Efficiency of IRES and 3Ј-End Variants of Luciferase Fusion RNAs Studied in Mice, HeLa Cells, and RRLs
Considerable effort is being devoted to the identification of potential inhibitors of different steps in the HCV life cycle. However, before candidate inhibitors such as antisense oligonucleotides and ribozymes can be tested in humans, preclinical small-animal model systems will be required to assess their safety and efficacy. Preliminary studies showed that transfection of both luciferase mRNAs containing or lacking the 5Ј-UTR of HCV led to emission of light in the liver of transfected mice. This finding demonstrated for the first time that the HCV IRES was functional in mouse liver (data not shown). This finding indicates that hydrodynamic RNA transfection could be used to test potential translational inhibitors for biochemical studies of IRES function in mice. However, such a system would only be useful if proper translational regulation of the IRES was maintained. To assess translational regulation in this novel mouse model system, we compared the translational efficiencies of several IRES variants in mice with standard in vitro model systems such as HeLa cells and RRLs. Although none of these model systems completely recapitulates HCV translation in an infected human liver, hydrodynamic RNA transfection provides the opportunity, for the first time, to monitor HCV translational regulation within an intact organ (the liver).
A number of groups have reported differences between in vitro and cell culture measurements of HCV IRES variant activities [5, 11, 12] . There are also conflicting reports as to the effect of a cap on IRES activity [30, 31] , and the effect of the HCV 3Ј-UTR on translation remains unclear [5, 32] . Therefore, we conducted a comparative analysis of IRES translation in nuclease-treated RRLs, HeLa cells, and mice (Fig. 6) . 33] . It has also been suggested [5, 32] that proteins bound to the IRES and the HCV 3Ј-UTR might circularize the HCV genomic RNA and thereby regulate translation. To assess the effect of 5Ј-capping and the presence of the HCV 3Ј-UTR sequences on translation from an HCV IRES-luciferase fusion, we injected capped and uncapped transcripts either lacking a 3Ј-UTR, or containing the complete HCV 3Ј-UTR or a poly(A) tail into mice (Fig. 6B) . Names of constructs containing a cap, HCV 3Ј-UTR, or poly(A) tail start with "Cap" or end with "3Ј-UTR" or "PolyA," respectively. The HCV 3Ј-UTR does not contain a poly(A) tail; however, a construct with a poly(A) tail was included to determine if the HCV 3Ј-UTR and a poly(A) tail were interchangeable. In all IRES experiments, values are reported as percentage activity compared with HCV 3Ј-UTR (n = 10 for studies with HCV3'UTR, HCVpolyA, and HCVNoUTR; n = 5 for all remaining variants). In mice, HCV3ЈUTR, HCVpolyA, and CapHCVPolyA expressed similar levels of luciferase, but expression from CapHCVNoUTR and HCVNoUTR RNA was low. The translational activity of CapHCV3ЈUTR was 68% of that of HCV3ЈUTR. Animals that received HCVPolyA, HCV3'UTR, CapHCVPolyA, and CapHCV3ЈUTR were imaged again at 24 hours and had approximately 4%, 4%, 7%, and 7%, respectively, of their original activity. From this, we can estimate that CapHCVPolyA and CapHCV3ЈUTR have similar stabilities, as do HCVPolyA and HCV3ЈUTR. Capped transcripts appeared to be slightly more stable than uncapped transcripts. The lack of expression from HCVNoUTR and CapHCVNoUTR may be due to RNA instability or an enhancement of translation by the 3Ј-UTR.
Effect of 5Ј Cap and HCV 3Ј-UTR or 3Ј Poly(A) on Translation Studies of cap-dependent translation in yeast and RRLs have suggested that interactions between cap-binding proteins and poly(A)-binding protein circularize mRNAs and enhance translation in eukaryotes [reviewed in
The effect of a cap and 3Ј-UTR was different in the three model systems. Both HeLa cells and mice required a poly(A) tail or HCV 3Ј-UTR for efficient translation (or RNA stability), but RRLs did not. Without a cap, HCV3'UTR and HCVPolyA translated equally well in mice, HeLa cells, and RRLs. Addition of a cap to HCVPolyA did not affect translation in mice. In contrast, the cap increased translation in HeLa cells and decreased translation in RRLs (270% and 50%, respectively). The presence of a cap decreased translation of CapHCV3ЈUTR in mice, HeLa cells, and RRLs to 68%, 24%, and 38%, respectively. This suggests that (1) a 3Ј-UTR is required for efficient translation or RNA stability in mice and HeLa cells but not in RRLs, (2) a cap and poly(A) tail synergistically enhance translation in HeLa cells, and (3) a cap inhibited translation in the context of the HCV 3Ј-UTR. All remaining IRES studies were conducted with uncapped RNAs ending in the HCV 3Ј-UTR, to mimic translation from the viral RNA.
Effect of Start Codon Mutations on Translation from the HCV IRES
Several reports showed that initiator codons other than AUG were functional in the context of the HCV IRES. A UUG codon has been shown to be functional in cell lysates and Huh-7 cells [34] . Studies in RRLs had indicated that IRESs with CUG and AUU start codons retained 90% activity [35] .
To see if start codons other than AUG could be used in mice, we tested the variants CUG3'UTR and GUG3'UTR (AUG→CUG or GUG, respectively; Figs. 6A and 6B). In mice and HeLa cells, significant translational reductions were observed with CUG3'UTR (22% and 9.9%, respectively) and GUG3ЈUTR (19% and 7.8%, respectively). A CUG or GUG codon decreased translation to a lesser degree in RRLs (58% and 62%, respectively). These data suggest that mutations of the initiator codon are poorly tolerated in vivo, and RRLs have less stringent initiator codon requirements compared with HeLa cells and mice.
Effect of Internal Bulge Mutation of Domain IIId
Domain IIId has been shown to be critical for IRES function [13, [36] [37] [38] [39] [40] . Most substitutions in this domain result in drastic reductions in translation in vitro and in culture, although some substitutions result in reductions of only 50-60%. The variant, IIId3'UTR, contained mutations in the internal bulge of IIId, which forms a loop E motif, a common stable RNA fold (Fig. 6A, legend) [41] . Mutations in the loop E motif of domain IIId resulted in activities of 41%, 3.4%, and 59%, respectively, in mice, HeLa cells, and RRLs (Fig. 6B) . Thus some perturbation of the loop E motif in domain IIId is tolerated in mice and RRLs but not in HeLa cells.
Domains II and III Are Essential for Translation
We measured translational activities in mice for several deletion mutants Del(II)3ЈUTR, Del(IIIb)3ЈUTR, Del(II+IIIb)3ЈUTR, Del(IIa-IIIc)3ЈUTR, Del(IIa-IIId)3ЈUTR, which lacked domains II, IIIb, II and IIIb, II through IIIc, and II through IIId, respectively (Figs. 6A and 6B) . Deletion of domains II and IIIb reduced translation to 2.7% and 20%, respectively. Deletion of domains II and IIIb, II through IIIc, and II through IIId decreased activity to 2.9%, 0.28%, and 0.40%, respectively.
We saw similar trends in the three model systems with all the large deletion mutants, except Del(IIIb)3ЈUTR. In all cases, RRLs showed the smallest decrease in translation, indicating that this system is the least stringent. Deletion The activity increase in RRLs upon deletion of domain IIIb was surprising, because IIIb comprises the eukaryotic initiation factor-3 (eIF3)-binding site [37, 42] . The 40S ribosomal subunit binds to the IRES in the absence of any other translational factors [43] . However, ribosomal 48S complex formation is enhanced by eIF3 and is absolutely required for 80S complex formation on the HCV IRES. Binding studies as well as chemical and enzymatic protection studies indicate that eIF3 binds to domain IIIb [37, 42] , and deletion of IIIb abrogates eIF3 binding [42] . Previously, Honda et al. [13] reported that domain IIIb was required in RRLs, but their deletion mutant did not include a tetraloop sequence to promote proper folding.
The above results indicate that translational regulation in mice and HeLa cells was similar. RRLs seemed to have more relaxed translational regulation, although for gross mutations, trends were similar to those observed in mice and HeLa cells. There are, however, some interesting differences between the model systems that could provide the basis for further studies. We conclude that IRES RNAs introduced into the livers of mice by hydrodynamic RNA transfection show relevant translational regulation. Therefore, the mouse model system described here is suitable for the assessment of HCV translational inhibitors in vivo.
DISCUSSION
Development of novel therapeutics for the treatment of HCV has been hampered by the lack of small-animal model systems. In this study, we have attempted to develop a mouse model system to study HCV RNA translational regulation. Hydrodynamic RNA transfection allowed transfer of RNA to the cytoplasm of liver cells, the desired subcellular locale for HCV model studies. Translation of transfected RNAs was dependent on RNA dose.
We have demonstrated that the HCV IRES is functional in mouse liver. It is clear from our data that the lack of viral replication observed upon transfection with fulllength HCV genomic RNAs is not due to a translational deficiency of the HCV IRES in mouse liver. Translation from the IRES in mouse liver did not require a cap, although a 3Ј-UTR greatly enhanced translation. Surprisingly, a poly(A) tail and the HCV 3Ј-UTR appeared to be functionally equivalent in translational enhancement. Domains II, IIIb, IIIa through IIIc, the AUG initiator codon, and to a lesser degree, a loop E motif in IIId, appeared to be important for efficient translation in mice.
Important differences in IRES-driven translation were observed in mice, HeLa cells, and RRLs. Translation from an uncapped IRES was dependent on the presence of a 3Ј-UTR in mice and HeLa cells but not in RRLs. The mouse and HeLa data are consistent with a model in which the IRES and the HCV 3Ј-UTR (or poly(A) tail) interact via RNA-protein interactions to circularize the RNA and facilitate ribosome reloading. However, we cannot exclude the possibility that the lack of translation from HCVNoUTR was due to RNA instability.
These three systems respond very differently to the presence of a cap and initiator codon mutations. petitor RNA, 800 units of RNasin, and 2 ml of PBS at 25ЊC is shown. Numbering and IRES secondary structure based on Honda et al. [49] . IRESs comprise nucleotides 18-374. Names of constructs with a cap begin with "Cap". Names of constructs with wild-type IRESs begin with "HCV." CUG3ЈUTR and GUG3ЈUTR constructs have CUG and GUG initiator codons, respectively. CUGIIId3ЈUTR has an A residue inserted after nucleotides 274 and an A→U substitution at nucleotides 276. In Del(IIIb)3ЈUTR, nucleotides 178-221 were replaced with 5Ј-GGCCGAAAGGCC-3Ј. In the variants Del(II+IIIb)3ЈUTR, Del(IIa-IIIc)3ЈUTR, and Del(IIa-IIId)3ЈUTR, domain II was replaced with the sequence 5Ј-GGACTTCGGTGC-3Ј and domains IIIa, IIIb, and IIIc or IIIa, IIIb, IIIc, and IIId, respectively, were replaced with the sequence 5Ј-CTTCGG-3Ј, 5Ј-CTTCGG-3Ј, or 5Ј-GGCCGAAAGGCC-3Ј, respectively. It is clear from our comparison of mice, RRLs, and HeLa cells that RRLs are translationally promiscuous. Ribosomal subunits and translational factors such as eIF2 and eIF3 may be present in excess of physiological levels in nuclease-treated RRLs as a result of the depletion of other mRNAs. This may lead to a loss of translational regulation in nuclease-treated RRLs. It is comforting that translational activity in HeLa cells largely correlates with translational activity in the liver of a mammal. Further work, however, will be required to determine why mice and HeLa cells respond differently to a cap and mutation of domain IIId.
A B ARTICLE
As basic research into the mechanism of HCV IRES translational initiation progresses, novel inhibitors of HCV translation that target the IRES may be found. HeLa cell transfection will be a powerful tool to test these new approaches. However, before these new therapies are tested in humans, preclinical, small-animal model systems may serve to assess the efficacy, toxicity, and bioavailability of these new therapeutics. Many viruses of clinical and commercial importance, such as foot-andmouth disease, rhinovirus, hepatitis A, and bovine viral diarrhea virus also utilize IRES elements. As suggested by the study of Chang et al. [21] , hydrodynamic RNA transfection may be useful for development of small-animal models for these viruses.
MATERIALS AND METHODS
Plasmids and transcripts. Capped and uncapped RNA transcripts were made by runoff in vitro transcription using a mMessage Machine or Megascript Kit, respectively (Ambion, Austin, TX) and treated with DNase I. RNAs were purified using a membrane that retains DNA (RNeasy Midi Kit; Qiagen, Germany). Transcripts and transcription templates are listed in the following format: RNA / transcription template (company if applicable) / runoff enzyme (or supercoiled) / polymerase. Luciferase RNA / pSP6controlDNA (Promega) / XmnI / SP6; competitor RNA / pGEMEX-1 (Promega) / supercoiled / T7; antisense probe / pSP-luc+NF (Promega) / NheI / T7; sense probe / pSP-luc+NF (Promega)/ XhoI/SP6; HCVnoUTR / pHCVPolyA / BamHI / T7; HCVPolyA / pHCVPolyA / XmnI / T7; HCV3ЈUTR series / pHCV3ЈUTR / HpaI / T7; FIXRNA / phFIX / XmnI / SP6. The plasmid pWTHCV was created by amplifying the HCV IRES [44] by PCR using a primer containing a T7 promoter and inserting this fragment into the HindIII-NcoI sites of pGL3-Basic (Promega). The HindIII-XbaI fragment of the resulting plasmid was then ligated into pUC119. The plasmid pHCVPolyA was made by inserting the annealed primers 5Ј-CGAATTTTTTC(T 30 )G-3Ј and 5Ј-GATCC(A 30 )GAAAAAATTCGGTAC-3Ј into the BamHI-KpnI sites of pWTHCV. The plasmids used in Fig. 6 were made from pWTHCV by introducing the changes listed in the legend of Fig. 6 using a QuikChange mutagenesis kit (Stratagene, La Jolla, CA). The entire HCV 3Ј-UTR was amplified by PCR from the plasmid p90FLHCV [44] (from Charles Rice) with primers that contained the recognition sites for BamHI and KpnI. This fragment was inserted into the BamHI-KpnI sites of the plasmids generated using the QuikChange mutagenesis kit. The human FIX gene was amplified from pV4.1e-h.FIX [45] using the primers 5Ј-AATAATCTAGAGGGAAAGT-GATTAGTTAGTGAGA GGCCCTG-3Ј and 5Ј-AATAACTGCAGCACCAT-GCAGCGCGTGACCATG-3Ј and inserted as a PstI-XbaI fragment into pSP64 poly(A) to make phFIX.
In situ hybridization and human FIX ELISA. Probes were made using a DIG RNA Labeling Kit (Roche, Indianapolis, IN). Light microscopy in situ hybridization was done on paraffin-embedded sections as described [44] . Electron microscopy in situ hybridization was done on glutaraldehyde-fixed and L.R. white-embedded sections and stained as described (http://biochem.roche.com/prod_inf/manuals/InSitu/InSi_toc.htm). Serum FIX levels were determined by ELISA as described [46] .
Human FIX ELISA and quantitative RT-PCR. Serum FIX levels were determined by ELISA as described [46] . HCV RT-PCR was as described [47] . GAPD RT-PCR was done using rodent GAPD kit (PE Biosystems, Foster City, CA).
In vitro translation. We used 100 ng of capped or uncapped RNA to program RRLs (Promega), as recommended by the manufacturer, except that reactions were scaled to 12.5 l. Products of the translation reaction were measured enzymatically using the luciferase assay system (Promega).
HeLa cell RNA transfections. After 2.5 ϫ 10 5 cells were seeded in 35-mm plates and incubated overnight, 1 g of capped or uncapped RNA was transfected using 10 l Lipofectin (Gibco/BRL, Carlsbad, CA) as described [48] . Cells were pelleted 3 hours post-transfection, resuspended in 100 l passive lysis buffer (Promega), and subjected to two cycles of freezing and thawing. Cellular debris was sedimented at 14,000g for 1 minute, and 20 l of the supernatant was assayed using the luciferase assay system (Promega).
Injections and imaging. RNAs, RNasin, and competitor RNA were mixed, added to 2 ml of PBS, and steadily injected in the tail vein of mice over 4-5 seconds. Reproducibility of hydrodynamic transfection is highly dependent on the quality of injection and requires some practice. It is essential that the rate of injection be consistent from injection to injection. See Liu et al. [18] for a discussion of the parameters that influence hydrodynamic transfection. Animals that did not receive the entire volume in a single bolus were not imaged. At indicated times, 80 l of 30 mg/ml luciferin was injected i.p. At 10 minutes postinjection, live anesthetized mice were imaged for 2 or 5 minutes. An intensified charge-coupled device (CCD) camera (model C2400-32; Hamamatsu, Japan) was used as described [25] . Raw values are reported as relative detected light per minute, and standard errors are shown. We obtained 18-to 22-g female BALB/c or NOD/LtSz-Prkdcscid mice from Jackson Laboratory (Bar Harbor, ME). Animals were treated according to NIH Guidelines for Animal Care and the Guidelines of Stanford University.
